Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

  1. Home
  2. PLCO
  3. Approved Projects

Approved PLCO Projects

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies
Reset

Results: 1030 (Showing 41 to 60) — Export these results

Name Principal Investigator Institution Study Date Approved Project ID
Developing a metabolite-based biomarker panel for prostate cancer detection and prognosis in African-American men Arun Sreekumar Baylor College of medicine PLCO Feb 19, 2020 PLCO-583
Second-hand smoke (SHS) and mortality in never-smoking women Neal Freedman NCI PLCO Feb 19, 2020 PLCO-586
A new mathematical model for the computation of optimal screening frequencies for lung and colorectal cancer Johannes Reiter Stanford University PLCO Feb 7, 2020 PLCO-581
Bayesian network in differential diagnosis of head and neck cancer Kamila Bukirova Near East University PLCO Feb 7, 2020 PLCO-571
Evaluation of dietary methionine intake and breast cancer incidence Vincent Cryns University of Wisconsin Madison PLCO Feb 7, 2020 PLCO-579
A new method to estimate the predictive value in a screening program Jian-Lun Xu NCI PLCO Feb 7, 2020 PLCO-580
Secondary analysis of association between ethnicity and endometriosis when adjusted for age at first pregnancy using data from the PCLO-dataset Frank Teunissen London School of Hygiene and Tropical Medicine PLCO Feb 3, 2020 PLCO-569
Clicque CLARA Rebuild Zui Yong Poong CLICQUE TECHNOLOGY SDN. BHD. PLCO Feb 3, 2020 PLCOI-575
Evaluating existing data on circulating inflammatory markers in relation to history of benign gynecologic pathology and history of oral contraceptive use. Lauren King NCI-DCEG PLCO Jan 30, 2020 PLCO-576
Use of Tobacco Biomarkers in Lung Cancer Risk Assessment Christine Lambert University of Minnesota PLCO Jan 30, 2020 PLCO-563
Prostate cancer risk prediction using clinical risk factors and genetics Renee George Multimodal Imaging Services Corporation, dba HealthLytix PLCO Jan 30, 2020 PLCO-574
Identification of High-Risk Cohorts using PLCO data for Targeted Gastric Cancer Prevention and Control Strategies Haejin In Albert Einstein College of Medicine PLCO Jan 27, 2020 PLCO-567
Uncovering roles of polyunsaturated fatty acids (PUFA) in pancreatic cancer etiology: a gene-diet interaction study Lang Wu University of Hawaii at Manoa PLCO Jan 27, 2020 PLCO-573
Dietary fiber, whole grains and risk of hepatocellular carcinoma Katherine McGlynn National Cancer Institute PLCO Jan 27, 2020 PLCO-554
Development of a machine learning algorithm for generating realistic synthetic electronic healthcare records (Prosate and Breast) Andreas Maier FAU Erlangen Nürnberg PLCO Jan 27, 2020 PLCO-570
Cell Free DNA Methylome for Lung Cancer Early Detection Rayjean Hung Sinai Health System PLCO Jan 23, 2020 2019-1024
Cell Free DNA Methylome for Pancreatic Cancer Early Detection Rayjean Hung Sinai Health System PLCO Jan 23, 2020 2019-1023
Helicobacter pylori strain-specific blood biomarker and lung cancer risk Qiuyin Cai Vanderbilt University Medical Center PLCO Jan 10, 2020 2019-1026
Total antioxidant capacity and pancreatic cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Zhong Guo-Chao The Second Affiliated Hospital of Chongqing Medical University PLCO Jan 8, 2020 PLCO-565
Vitamin K intake and breast, endometrial, ovarian and colorectal cancer incidence and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial Kang Wang The First Affiliated hospital of Chongqing Medical university PLCO Jan 8, 2020 PLCO-566